HER3: Emerging as a Key Epidermal Growth Factor Receptor (EGFR) in cancer immunotherapy

HER3 News

HER3: Emerging as a Key Epidermal Growth Factor Receptor (EGFR) in cancer immunotherapy
Epidermal Growth Factor Receptor (EGFR)Cancer Immunotherapy
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 24 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

This product profile highlights HER3 (ERBB3), a crucial member of the Epidermal Growth Factor Receptor (EGFR) family, implicated in key cellular processes such as proliferation, survival, and differentiation through the PI3K/Akt, MAPK, and JAK/STAT signaling pathways.

is a crucial member of the Epidermal Growth Factor Receptor family. It plays a significant role in cellular proliferation, survival, and differentiation via the PI3K/Akt, MAPK, and JAK/STAT signaling pathways. Even though HER3 signaling is essential for tissue growth and homeostasis, dysregulation of this signaling pathway is linked to the advancement of cancer, making it a potentially effective therapeutic target for several cancers.

Under typical physiological circumstances, HER3 plays a role in tissue growth and homeostasis. On the other hand, dysregulation of HER3 signaling has been linked to several cancers, including those of the breast, ovaries, prostate, and stomach. The distinctive characteristic of HER3 is its strong ability to form heterodimers with other members of the ERBB family, especially HER2, which can result in increased oncogenic signaling and resistance to treatment.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Epidermal Growth Factor Receptor (EGFR) Cancer Immunotherapy

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

This hair growth serum reduces loss by 95% and growth by 85% in monthsThis hair growth serum reduces loss by 95% and growth by 85% in monthsLet’s ‘grow’ girls.
Read more »

This hair growth serum reduces loss by 95% and growth by 85% in monthsThis hair growth serum reduces loss by 95% and growth by 85% in monthsLet’s ‘grow’ girls.
Read more »

£29 hair growth serum beauty buffs insist gives ‘double the growth’ in 5 weeks£29 hair growth serum beauty buffs insist gives ‘double the growth’ in 5 weeks'In 5 weeks my hair had thickened up beautifully as it was quite a lot thinner on the top, but now it's thick all over. I'm looking forward to seeing my hair grow over the coming months and will continue to use the serum.'
Read more »

Greg Taylor wants Adam Idah stay as Kyogo factor and big moments highlightedGreg Taylor wants Adam Idah stay as Kyogo factor and big moments highlightedCameron Carter-Vickers has also backed boss Brendan Rodgers' call to get a £6million deal over the line.
Read more »

Tattoos could be a risk factor for lymphoma, study suggestsTattoos could be a risk factor for lymphoma, study suggestsA new study from Lund University in Sweden suggests that tattoos could be a risk factor for cancer in the lymphatic system, or lymphoma.
Read more »

'Deeply disturbing' footage from 1970s uncovered of Northern Irish blood victim receiving Factor 8'Deeply disturbing' footage from 1970s uncovered of Northern Irish blood victim receiving Factor 8Paul Kirkpatrick was diagnosed with Hepatitis C after being given contaminated blood products as a child.
Read more »



Render Time: 2025-02-19 20:19:22